GGrantIndex
← Leaderboards

David J Mangelsdorf

University Of Texas Sw Med Ctr/Dallas

$11,431,238
Attributed
$12,353,082
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.8M · FY200524
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$23,271,374 · 7

By mechanism

P01$10,918,292 · 1
T32$7,366,162 · 1
RL1$1,921,160 · 1
R01$1,843,688 · 1
U19$1,194,572 · 1
R13$27,500 · 2

Top collaborators

Most similar at University Of Texas Sw Med Ctr/Dallas

Same institution · by research overlap

Others in their field

Top investigators on “Hormones

Research focus

HormonesMediatingReceptorTissuesLiverResponseMetabolic DiseasesInsightBaseFibroblast Growth Factor 21Nuclear ReceptorsMetabolismLifeNeuronsBehavioralMouse ModelAgingEnergy BalanceClinical TrialsAdipose TissueMolecularGeneticHepaticGenes

Grant awards (48)

Coordinate Regulation of an Alcohol Protective Response by the Liver-derived Hormone FGF21$369,000
R01 · FY2024 · AA
Coordinate Regulation of an Alcohol Protective Response by the Liver-derived Hormone FGF21$369,000
R01 · FY2023 · AA
Coordinate Regulation of an Alcohol Protective Response by the Liver-derived Hormone FGF21$369,000
R01 · FY2022 · AA
Coordinate Regulation of an Alcohol Protective Response by the Liver-derived Hormone FGF21$368,906
R01 · FY2021 · AA
Impact of FGF21 on healthspan and lifespan$1,983,293
P01 · FY2020 · AG
Coordinate Regulation of an Alcohol Protective Response by the Liver-derived Hormone FGF21$367,782
R01 · FY2020 · AA
Mechanisms of Drug Action and Disposition$329,596
T32 · FY2020 · GM · contact PI
Impact of FGF21 on healthspan and lifespan$1,997,502
P01 · FY2019 · AG
Mechanisms of Drug Action and Disposition$366,853
T32 · FY2019 · GM · contact PI
Impact of FGF21 on healthspan and lifespan$291,000
P01 · FY2019 · AG
Impact of FGF21 on healthspan and lifespan$2,011,300
P01 · FY2018 · AG
Impact of FGF21 on healthspan and lifespan$418,269
P01 · FY2018 · AG
Mechanisms of Drug Action and Disposition$361,539
T32 · FY2018 · GM · contact PI
Impact of FGF21 on healthspan and lifespan$2,024,695
P01 · FY2017 · AG
Mechanisms of Drug Action and Disposition$320,720
T32 · FY2017 · GM · contact PI
Impact of FGF21 on healthspan and lifespan$138,000
P01 · FY2017 · AG
Impact of FGF21 on healthspan and lifespan$2,054,233
P01 · FY2016 · AG
Mechanisms of Drug Action and Disposition$316,175
T32 · FY2016 · GM · contact PI
Mechanisms of Drug Action and Disposition$389,614
T32 · FY2015 · GM · contact PI
Mechanisms of Drug Action and Disposition$354,025
T32 · FY2014 · GM · contact PI
Mechanisms of Drug Action and Disposition$348,750
T32 · FY2013 · GM · contact PI
Mechanisms of Drug Action and Disposition$348,750
T32 · FY2012 · GM · contact PI
Role of FGF21 as a Hormonal Mediator of PPARalpha Actions, Project 4 of 10$377,381
RL1 · FY2011 · GM · contact PI
Mechanisms of Drug Action and Disposition$343,622
T32 · FY2011 · GM · contact PI
Expression Profiling in Physiologic and Pathophysiologic Processes$194,925
U19 · FY2011 · DK · contact PI
Role of FGF21 as a Hormonal Mediator of PPARalpha Actions, Project 4 of 10$381,193
RL1 · FY2010 · GM · contact PI
Mechanisms of Drug Action and Disposition$355,662
T32 · FY2010 · GM · contact PI
Expression Profiling in Physiologic and Pathophysiologic Processes$202,800
U19 · FY2010 · DK · contact PI
Role of FGF21 as a Hormonal Mediator of PPARalpha Actions, Project 4 of 10$385,043
RL1 · FY2009 · GM · contact PI
Mechanisms of Drug Action and Disposition$361,043
T32 · FY2009 · GM · contact PI
Expression Profiling in Physiologic and Pathophysiologic Processes$202,800
U19 · FY2009 · DK · contact PI
Role of FGF21 as a Hormonal Mediator of PPARalpha Actions, Project 4 of 10$385,043
RL1 · FY2008 · GM · contact PI
Mechanisms of Drug Action and Disposition$358,621
T32 · FY2008 · GM · contact PI
Expression Profiling in Physiologic and Pathophysiologic Processes$202,800
U19 · FY2008 · DK · contact PI
Role of FGF21 as a Hormonal Mediator of PPARalpha Actions, Project 4 of 10$392,500
RL1 · FY2007 · GM · contact PI
Expression Profiling in Physiologic and Pathophysiologic Processes$391,247
U19 · FY2007 · DK · contact PI
Mechanisms of Drug Action and Disposition$358,621
T32 · FY2007 · GM · contact PI
Mechanisms of Drug Action and Disposition$342,493
T32 · FY2006 · GM · contact PI
MECHANISMS OF DRUG ACTION AND DISPOSITION$363,168
T32 · FY2005 · GM
MECHANISMS OF DRUG ACTION AND DISPOSITION$373,629
T32 · FY2004 · GM
Nuclear Receptors: Orphan Brothers$17,500
R13 · FY2004 · DK
MECHANISMS OF DRUG ACTION AND DISPOSITION$363,209
T32 · FY2003 · GM
MECHANISMS OF DRUG ACTION AND DISPOSITION$339,726
T32 · FY2002 · GM
Conference on Nuclear Receptor Superfamily$10,000
R13 · FY2002 · DK
Genomic &Metabolic Profiling of Orphan Nuclear Receptors II$0
U19 · FY2002 · DK
Genomic &Metabolic Profiling of Orphan Nuclear Receptors II$0
U19 · FY2002 · DK
MECHANISMS OF DRUG ACTION AND DISPOSITION$315,672
T32 · FY2001 · GM
MECHANISMS OF DRUG ACTION AND DISPOSITION$354,674
T32 · FY2000 · GM